Literature DB >> 21895674

Demographics of apheresis platelet donors in five blood centers in China.

Nan Guo1, Jingxing Wang, Paul Ness, Fuzhu Yao, Xiangdong Dong, Xinhong Bi, Heili Mei, Julin Li, Weilan He, Yunlai Lu, Hongli Ma, Xiuqiong Wen, Mei Huang, Jing Liu, David J Wright, Hua Shan.   

Abstract

BACKGROUND: Blood component donations by apheresis has become more common in modern blood transfusion practices. However, apheresis donation still remains less common in China. This study describes the demographic profile and transfusion-transmissible infection (TTI) prevalence among donors making apheresis platelet (AP) donations compared to those making whole blood (WB) donations and the differences among five geographically diverse blood centers in China. STUDY DESIGN AND METHODS: This is a descriptive study using data from all successful donations at the five blood centers in 2008 and 2009. Donor demographic and TTI screening reactive rates were collected for WB and AP donations and blood centers. Logistic regression was used to identify independent factors associated with AP donations.
RESULTS: From January 1, 2008, to December 31, 2009, there were 512,594 WB and 26,199 AP donations at five blood centers. AP donations accounted for 4.9% of all donations. AP donations have lower reactive rate than WB donations for hepatitis B virus surface antigen, hepatitis C virus antibodies, human immunodeficiency virus antibodies, and syphilis screening testing. Males, donors older than 25 years old, non-Han donors, and donors with below high school educational level were more likely to make AP donations. The characteristics of AP donations differed among the five Chinese blood centers.
CONCLUSION: Our analysis suggests that the characteristics of AP donations in China are different from WB donations and differ among the five Chinese blood centers. Some of the differences are likely due to different recruitment policies. Further studies should be conducted to understand what motivates Chinese blood donors to participate as AP donors.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895674     DOI: 10.1111/j.1537-2995.2011.03328.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.

Authors:  Wenjie Sun; Chi-Pang Wen; Jie Lin; Christopher Wen; Xia Pu; Maosheng Huang; Min Kuang Tsai; Chwen Keng Tsao; Xifeng Wu; Wong-Ho Chow
Journal:  Cancer Epidemiol       Date:  2015-01-16       Impact factor: 2.984

2.  Frequencies and ethnic distribution of ABO and RhD blood groups in China: a population-based cross-sectional study.

Authors:  Jue Liu; Shikun Zhang; Qiaomei Wang; Haiping Shen; Yiping Zhang; Min Liu
Journal:  BMJ Open       Date:  2017-12-03       Impact factor: 2.692

3.  Risk factors associated with the occurrence of adverse events in plateletpheresis donation.

Authors:  Maria Helena Barbosa; Karla Fabiana Nunes da Silva; Dieska Quintiliano Coelho; Jordânia Lumênia Tavares; Luciana Falcão da Cruz; Márcia Helena Kanda
Journal:  Rev Bras Hematol Hemoter       Date:  2014-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.